Neurology

Study shows eplontersen maintains a consistent and sustained treatment effect and reinforces its potential treating hereditary transthyretin-mediated amyloid polyneuropathy, which can lead to heart failure.

Session at the 2023 Asembia Summit notes that pharmacists play a particularly important role in the large multidisciplinary care team needed for Rett syndrome management.

Infants diagnosed with invasive Group B Streptococcus meningitis had an increased risk of developing epilepsy if the mother was of lower income.

Six weeks after infusion of GD2-CART01, 9 of 27 patients (33%) with relapsed or refractory high-risk neuroblastoma had a complete response or maintained a complete response.

Lowering blood pressure could be dangerous for people with normal blood pressure.

Clinicians are often focused on reducing brain damage after traumatic injury, but considering nutrition is an important component to healing.

Atogepant (Qulipta; AbbVie) is the first and only oral calcitonin gene-related peptide receptor antagonist to gain FDA approval for the prevention of episodic and chronic migraine.

The efficacy and tolerability of rizatriptan for acute migraine treatment has been well established.

Pharmacists are crucial in supporting patients with attention-deficit hyperactivity disorder as shortages of Adderall continue.

As more drugs gain coverage, decision-makers will need to more accurately diagnose Alzheimer disease, especially in the community setting.

The implementation of genetic testing for patients prescribed medications associated with progressive multifocal leukoencephalopathy is likely to improve safety outcomes.

Although attention-deficit/hyperactivity disorder (ADHD) is not as common in adults, it can still be present and bothersome, however, adults with ADHD may have learned to hide it a bit better than children.

Children in the LT-001 study treated after onset achieved or maintained additional milestones up to 7.5 years after 1-time intravenous infusion, Novartis says.

Strong interprofessional team helps ensure safe transitions and minimize adverse events, medication errors

Liquid formulations of dabrafenib plus trametinib were also approved, marking the first time a BRAF/MEK inhibitor has been developed in a formulation suitable for patients as young as 1 year of age.

Perceived stress and cognitive performance are independently associated. Stress can also increase the risk of worsening cognition.

Trofinetide is the first and only drug approved for the treatment of Rett syndrome.

Zavegepant is the only calcitonin gene-related peptide receptor antagonist nasal spray indicated for acute treatment of migraine in adults and can provide pain relief in 15 minutes.

Migraines are common yet misunderstood, therefore it is important that various treatment options be examined and offered to this patient population.

A patient’s neurological symptoms diminished when he discontinued a biosimilar and started various new treatments.

Investigators noted medication prescription disparities among patients with dementia despite factoring for age and sex.

Vitamin D may reduce the risk of dementia because it clears amyloid that accumulates in the brain.

Friedreich’s ataxia is a rare neuromuscular disease that affects approximately 5000 patients in the United States.

Zavegepant is the first calcitonin gene-related peptide receptor for migraines in development as an intranasal formulation studied in a phase 3 trial.

New research from Harvard Medical School could be a game changer for the management of headaches associated with anti-CGRP migraine therapy.